# OnCo record data-monitoring-committee (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/data-monitoring-committee/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "data-monitoring-committee" ;
  schema:name "Data monitoring committee (DSMB, IDMC)"@en ;
  schema:alternateName "data monitoring committee"@en, "data and safety monitoring board"@en, "data safety monitoring board"@en, "independent data monitoring committee"@en, "DSMB"@en, "DMC"@en, "IDMC"@en, "DSMBs"@en, "IDMCs"@en, "independent data monitoring committees"@en, "data monitoring committees"@en, "monitoring committee"@en, "safety monitoring board"@en, "recommended by the DMC"@en, "on the recommendation of the IDMC"@en, "recommended stopping"@en, "recommended unblinding"@en, "recommended continuation"@en, "recommended the trial continue"@en, "unblinded statistician"@en, "independent statistician"@en, "steering committee"@en, "trial steering committee"@en, "closed session"@en ;
  schema:description "A data monitoring committee is a small group of independent doctors and statisticians who see the unblinded results while a trial is running and tell the sponsor to stop, change or continue, so that neither patients nor the sponsor are exposed to what the data are showing before the trial is done."@en ;
  schema:url <https://onco.cc/terms/data-monitoring-committee/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Data_monitoring_committee> ;
  schema:citation <https://en.wikipedia.org/wiki/Data_monitoring_committee>, <https://www.fda.gov/regulatory-information/search-fda-guidance-documents/establishment-and-operation-clinical-trial-data-monitoring-committees> ;
  onco:related <https://onco.cc/terms/interim-analysis/>, <https://onco.cc/terms/futility/>, <https://onco.cc/terms/group-sequential-design/>, <https://onco.cc/terms/ethics-review/>, <https://onco.cc/terms/clinical-equipoise/>, <https://onco.cc/terms/trial-protocol/>, <https://onco.cc/terms/trial-lifecycle/>, <https://onco.cc/terms/seamless-adaptive/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:trials <https://onco.cc/trials/adaura/>, <https://onco.cc/trials/javelin-hn-100/>, <https://onco.cc/trials/trilynx/>, <https://onco.cc/trials/magnitude/>, <https://onco.cc/trials/dream3r/> .